Jill J. Hauer

ORCID: 0000-0003-3455-6536
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Complement system in diseases
  • Renal Diseases and Glomerulopathies
  • Blood groups and transfusion
  • Renal Transplantation Outcomes and Treatments
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Genetic and Kidney Cyst Diseases
  • Hemophilia Treatment and Research
  • Phagocytosis and Immune Regulation
  • Blood Coagulation and Thrombosis Mechanisms
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Adenosine and Purinergic Signaling
  • Chronic Myeloid Leukemia Treatments
  • Liver Disease and Transplantation
  • Holomorphic and Operator Theory

University of Iowa
2017-2023

Renal Research Institute
2017-2023

Carver Bible College
2023

Iowa City Public Library
2023

The thrombotic microangiopathies (TMAs) and C3 glomerulopathies (C3Gs) include a spectrum of rare diseases such as atypical hemolytic uremic syndrome, thrombocytopenic purpura, C3GN, dense deposit disease, which share phenotypic similarities underlying genetic commonalities. Variants in several genes contribute to the pathogenesis these diseases, identification variants may inform diagnosis treatment affected patients. We have developed validated comprehensive panel that screens all exons...

10.1681/asn.2015040385 article EN Journal of the American Society of Nephrology 2015-08-18

IntroductionC3 Glomerulopathy (C3G) is an ultra-rare renal disease characterized by deposition of complement component C3 in the glomerular basement membrane. Rare and novel genetic variation genes autoantibodies to proteins are commonly identified C3G population thought drive underlying dysregulation that results damage; however, heterogeneity rarity make accurately defining characteristics difficult.MethodsHere we present a retrospective analysis Molecular Otolaryngology Renal Research...

10.1016/j.ekir.2023.11.025 article EN cc-by-nc-nd Kidney International Reports 2023-11-30

IntroductionC3 Glomerulopathy (C3G) is an ultra-rare renal disease mediated by dysregulation of the alternative pathway (AP) complement system. Rare and novel genetic variation in genes autoantibodies to proteins are commonly identified C3G population thought drive dysregulation. Most C3 C5 nephritic factors that bind stabilize AP convertases, respectively. The rare heterogeneous nature makes understanding how these immunologic may influence progression difficult. We hypothesize systemic...

10.1016/j.ekir.2022.04.036 article EN cc-by-nc-nd Kidney International Reports 2022-06-01
Coming Soon ...